Food intolerance/malabsorption in Hashimoto's thyroiditis.

Wolfgang J Schnedl, Simon Michaelis, Michael Schenk, Dietmar Enko, Sandra J Holasek

Abstract read

In one paragraph

Article in Clinics (Sao Paulo, Brazil), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Wolfgang J SchnedlDivision of Immunology, Otto Loewi Research Center, Medical University of Graz, Graz, Austria; General Internal Medicine Practice, Bruck, Austria. Electronic address: w.schnedl@dr-schnedl.at.

Simon MichaelisInstitute of Clinical Chemistry and Laboratory Medicine, Hospital Hochsteiermark, Leoben, Austria.

Michael SchenkDas Kinderwunsch Institut Schenk GmbH, Dobl, Austria.

Dietmar EnkoInstitute of Clinical Chemistry and Laboratory Medicine, Hospital Hochsteiermark, Leoben, Austria; Clinical Institute of Medical and Chemical Laboratory Diagnosis, Medical University of Graz, Graz, Austria.

Sandra J HolasekDivision of Immunology, Otto Loewi Research Center, Medical University of Graz, Graz, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextThe clinical significance of the interaction between the gastrointestinal system and the thyroid gland remains unclear. Moreover, a correlation between food intolerance/malabsorption, and thyroid disease, including Hashimoto's thyroiditis, awaits elucidation.

objectivesThis study set out with the objective of identifying food intolerance/malabsorption, including Fructose Malabsorption (FM), Histamine Intolerance (HIT), and Lactose Intolerance (LIT), in patients presenting with abdominal symptoms within the Irritable Bowel Syndrome (IBS) spectrum who had also Hashimoto's thyroiditis.

methodsIn this retrospective study, 221 patients with Hashimoto's thyroiditis, defined by elevated Thyroid Peroxidase Antibodies (TPO-Ab), were included. A subgroup of 50 abdominal asymptomatic Hashimoto's patients served as controls. Among 171 patients with abdominal symptoms FM and LIT were diagnosed using hydrogen breath tests, while HIT was defined by reduced serum diamine oxidase levels in combination with clinical response to a histamine-reduced diet.

resultsTwenty-two were identified with FM, 40 with HIT and 42 with LIT; 19 had both LIT and FM, 31 had LIT and HIT, and 17 had LIT, FM, and HIT. However, there were no statistically significant differences in TSH or TPO-Ab levels between patients with FM, HIT, LIT, or their combinations (p = 0.739 and p = 0.460, respectively). Thyroid function and TPO-Ab levels were similar between symptomatic and asymptomatic patients.

conclusionIn summary, this study assumes that food intolerance/malabsorption, including FM, HIT, and LIT, may coexist in patients with Hashimoto's thyroiditis who present with IBS-spectrum abdominal symptoms.

Indexed as

FructoseHashimoto's thyroiditisHistamineLactose intoleranceThyroid peroxidase

Identifiers

PMID42880128

DOI10.1016/j.clinsp.2026.101168

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.